11 research outputs found
Dysfunction of cortical GABAergic neurons leads to sensory hyper-reactivity in a Shank3 mouse model of ASD.
Hyper-reactivity to sensory input is a common and debilitating symptom in individuals with autism spectrum disorders (ASD), but the neural basis underlying sensory abnormality is not completely understood. Here we examined the neural representations of sensory perception in the neocortex of a Shank3B-/- mouse model of ASD. Male and female Shank3B-/- mice were more sensitive to relatively weak tactile stimulation in a vibrissa motion detection task. In vivo population calcium imaging in vibrissa primary somatosensory cortex (vS1) revealed increased spontaneous and stimulus-evoked firing in pyramidal neurons but reduced activity in interneurons. Preferential deletion of Shank3 in vS1 inhibitory interneurons led to pyramidal neuron hyperactivity and increased stimulus sensitivity in the vibrissa motion detection task. These findings provide evidence that cortical GABAergic interneuron dysfunction plays a key role in sensory hyper-reactivity in a Shank3 mouse model of ASD and identify a potential cellular target for exploring therapeutic interventions
Liao Yiwu und die Freiheit der Literatur. Mit Beiträgen von Karin Betz, Christoph König, Liao Yiwu und Herbert Wiesner
Textdokumentation zur Podiumsveranstaltung der Osnabrücker Friedensgespräche und des Germanistischen Kolloquiums der Universität Osnabrück am 27. Juni 201
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities
A successful structure-based design
of novel cyclic depsipeptides
that selectively target class I HDAC isoforms is described. Compound <b>11</b> has an IC<sub>50</sub> of 2.78 nM for binding to the HDAC1
protein, and the prodrugs <b>12</b> and <b>13</b> also
exhibit promising antiproliferative activities in the nanomolar range
against various cancer cell lines. Compounds <b>12</b> and <b>13</b> show more than 20-fold selectivity toward human cancer
cells over human normal cells in comparison with romidepsin (FK228),
demonstrating low probability of toxic side effects. In addition,
compound <b>13</b> exhibits excellent in vivo anticancer activities in a human prostate carcinoma (Du145) xenograft
model with no observed toxicity. Thus, prodrug <b>13</b> has
therapeutic potential as a new class of anticancer agent for further
clinical translation
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities
A successful structure-based design
of novel cyclic depsipeptides
that selectively target class I HDAC isoforms is described. Compound <b>11</b> has an IC<sub>50</sub> of 2.78 nM for binding to the HDAC1
protein, and the prodrugs <b>12</b> and <b>13</b> also
exhibit promising antiproliferative activities in the nanomolar range
against various cancer cell lines. Compounds <b>12</b> and <b>13</b> show more than 20-fold selectivity toward human cancer
cells over human normal cells in comparison with romidepsin (FK228),
demonstrating low probability of toxic side effects. In addition,
compound <b>13</b> exhibits excellent in vivo anticancer activities in a human prostate carcinoma (Du145) xenograft
model with no observed toxicity. Thus, prodrug <b>13</b> has
therapeutic potential as a new class of anticancer agent for further
clinical translation
Dysfunction of cortical GABAergic neurons leads to sensory hyper-reactivity in a Shank3 mouse model of ASD
Hyper-reactivity to sensory input is a common and debilitating symptom in individuals with autism spectrum disorders (ASD), but the neural basis underlying sensory abnormality is not completely understood. Here we examined the neural representations of sensory perception in the neocortex of a Shank3B−/− mouse model of ASD. Male and female Shank3B−/− mice were more sensitive to relatively weak tactile stimulation in a vibrissa motion detection task. In vivo population calcium imaging in vibrissa primary somatosensory cortex (vS1) revealed increased spontaneous and stimulus-evoked firing in pyramidal neurons but reduced activity in interneurons. Preferential deletion of Shank3 in vS1 inhibitory interneurons led to pyramidal neuron hyperactivity and increased stimulus sensitivity in the vibrissa motion detection task. These findings provide evidence that cortical GABAergic interneuron dysfunction plays a key role in sensory hyper-reactivity in a Shank3 mouse model of ASD and identify a potential cellular target for exploring therapeutic interventions.National Institutes of Health (Grant R01MH097104)NIMH (Grants P50MH094271, F32MH100749 and R01NS045130